BRUGGMANN, P.; BLACH, S.; DELTENRE, P.; FEHR, J.; KOUYOS, R. D.; LAVANCHY, D.; MÜLLHAUPT, B.; RAUCH, A.; RAZAVI, H.; SCHMID, P.; SEMELA, D.; STÖCKLE, M.; NEGRO, F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Medical Weekly, [S. l.], v. 147, n. 4546, p. w14543, 2017. DOI: 10.4414/smw.2017.14543. Disponível em: https://smw.ch/index.php/smw/article/view/2405. Acesso em: 19 apr. 2024.